Back to Trades
Tactic Pharma LLC
Chief Executive OfficerDirector10% OwnerCIK 0001727357
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025
Tactic Pharma LLC, Chief Executive Officer, Director, 10% Owner, has filed 1 SEC report (2025), all concentrated in Monopar Therapeutics (MNPR), totaling $35.0M in disclosed volume. Weighing $0 bought versus $35.0M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Sep 26 | MNPR Monopar Therapeutics | Tactic Pharma LLC | Chief Executive Officer, Director, 10% Owner | Sell | $35.0M |
1 filing